192 related articles for article (PubMed ID: 27206953)
1. Asparaginase-associated concurrence of hyperlipidemia, hyperglobulinemia, and thrombocytosis was successfully treated by centrifuge/membrane hybrid double-filtration plasmapheresis.
Wang T; Xu B; Fan R; Liu Z; Gong D
J Clin Lipidol; 2016; 10(3):646-9. PubMed ID: 27206953
[TBL] [Abstract][Full Text] [Related]
2. Prediction of immunoglobulin M reduction via therapeutic dose of simple plasma exchange and double filtration plasmapheresis using membrane separation in patients with hyperviscosity syndrome caused by Waldenstrom macroglobulinemia.
Miyamoto Y; Hamasaki Y; Matsumoto A; Doi K; Noiri E; Nangaku M
J Clin Apher; 2018 Oct; 33(5):611-615. PubMed ID: 30188580
[TBL] [Abstract][Full Text] [Related]
3. Isoagglutinin removal by plasma centrifugation or filtration (single or double): A prospective study in a single center.
Naciri Bennani H; Noble J; Chevallier E; Terrec F; Motte L; Giroux-Lathuile C; Bugnazet M; Imerzoukene F; Janbon B; Malvezzi P; Rostaing L; Jouve T
J Clin Apher; 2021 Feb; 36(1):149-160. PubMed ID: 33230824
[TBL] [Abstract][Full Text] [Related]
4. More selective removal of myeloperoxidase-anti-neutrophil cytoplasmic antibody from the circulation of patients with vasculitides using a novel double-filtration plasmapheresis therapy.
Gong D; Ji D; Xu B; Liu Z
Ther Apher Dial; 2013 Feb; 17(1):93-8. PubMed ID: 23379500
[TBL] [Abstract][Full Text] [Related]
5. Double filtration plasmapheresis: Review of current clinical applications.
Hirano R; Namazuda K; Hirata N
Ther Apher Dial; 2021 Apr; 25(2):145-151. PubMed ID: 32558286
[TBL] [Abstract][Full Text] [Related]
6. Double filtration plasmapheresis in the treatment of pancreatitis due to severe hypertriglyceridemia.
Galán Carrillo I; Demelo-Rodriguez P; Rodríguez Ferrero ML; Anaya F
J Clin Lipidol; 2015; 9(5):698-702. PubMed ID: 26350817
[TBL] [Abstract][Full Text] [Related]
7. Double-filtration plasmapheresis.
Tanabe K
Transplantation; 2007 Dec; 84(12 Suppl):S30-2. PubMed ID: 18162985
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of centrifugal-membranous hybrid double filtration plasmapheresis and membranous double filtration plasmapheresis on severe lupus nephritis.
Dong J; Huang L; Li C; Wu B; Yang X; Ge Y
Lupus; 2023 Aug; 32(9):1066-1074. PubMed ID: 37487569
[TBL] [Abstract][Full Text] [Related]
9. Comparison of three modalities of plasmapheresis on coagulation: Centrifugal, single-membrane filtration, and double-filtration plasmapheresis.
Marlu R; Naciri Bennani H; Seyve L; Noble J; Chevallier E; Motte L; Imerzoukene F; Bugnazet M; Christophe M; Malvezzi P; Jouve T; Rostaing L
J Clin Apher; 2021 Jun; 36(3):408-419. PubMed ID: 33506958
[TBL] [Abstract][Full Text] [Related]
10. The impact of therapeutic plasma exchange and double filtration plasmapheresis on hemostasis in renal transplant recipients.
Vatazin AV; Zulkarnaev AB
Ter Arkh; 2018 Jun; 90(6):22-27. PubMed ID: 30701900
[TBL] [Abstract][Full Text] [Related]
11. Protocol of comparison of the effects of single plasma exchange and double filtration plasmapheresis on peripheral lymphocyte phenotypes in patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: a monocentric prospective study with single-case experimental design.
Moranne O; Ion IM; Cezar R; Messikh Z; Prelipcean C; Chkair S; Thouvenot E; Tran TA; Corbeau P; Chevallier T
BMC Neurol; 2022 Aug; 22(1):293. PubMed ID: 35931957
[TBL] [Abstract][Full Text] [Related]
12. An effective LDL removal filter for the treatment of hyperlipidemia.
Matsuda Y; Sueoka A; Nosé Y
Artif Organs; 1995 Feb; 19(2):129-34. PubMed ID: 7763191
[TBL] [Abstract][Full Text] [Related]
13. Membranes for therapeutic apheresis.
Nakaji S; Yamamoto T
Ther Apher; 2002 Aug; 6(4):267-70. PubMed ID: 12164795
[TBL] [Abstract][Full Text] [Related]
14. Optimum albumin concentration of supplementation fluid for double filtration plasmapheresis.
Mineshima M; Agishi T; Hasuo Y; Era K; Suzuki T; Teraoka S; Ota K
Artif Organs; 1992 Oct; 16(5):510-3. PubMed ID: 10078302
[TBL] [Abstract][Full Text] [Related]
15. Double filtration plasmapheresis in different diseases in Thailand.
Lumlertgul D; Suteeka Y; Tumpong S; Bunnachak D; Boonkaew S
Ther Apher Dial; 2013 Feb; 17(1):99-116. PubMed ID: 23379501
[TBL] [Abstract][Full Text] [Related]
16. Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis.
Zhang YY; Tang Z; Chen DM; Gong DH; Ji DX; Liu ZH
BMC Nephrol; 2014 Aug; 15():128. PubMed ID: 25086644
[TBL] [Abstract][Full Text] [Related]
17. A controlled study of double filtration plasmapheresis in the treatment of active rheumatoid arthritis.
Yu X; Ma J; Tian J; Jiang S; Xu P; Han H; Wang L
J Clin Rheumatol; 2007 Aug; 13(4):193-8. PubMed ID: 17762452
[TBL] [Abstract][Full Text] [Related]
18. Fibrinogen reconstitution after therapeutic apheresis: Comparison of double-filtration plasmapheresis, plasma exchange, and immunoadsorption.
Jouve T; Marlu R; Naciri Bennani H; Noble J; Chevallier E; Motte L; Imerzoukene F; Malvezzi P; Rostaing L
J Clin Apher; 2021 Aug; 36(4):574-583. PubMed ID: 33783856
[TBL] [Abstract][Full Text] [Related]
19. Continuous monitoring of blood volume in double filtration plasmapheresis.
Mineshima M; Eguchi K; Horibe K; Yokoi R; Kaneko I; Kimata N; Sanaka T; Nihei H; Agishi T
ASAIO J; 1998; 44(5):M465-9. PubMed ID: 9804474
[TBL] [Abstract][Full Text] [Related]
20. The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. Updating.
Stefanutti C; Morozzi C; Perrone G; Di Giacomo S; Vivenzio A; D'Alessandri G
G Chir; 2012; 33(11-12):444-9. PubMed ID: 23140934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]